1. Home
  2. CYTK vs PPC Comparison

CYTK vs PPC Comparison

Compare CYTK & PPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$64.86

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Pilgrim's Pride Corporation

PPC

Pilgrim's Pride Corporation

HOLD

Current Price

$41.66

Market Cap

8.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
PPC
Founded
1997
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Meat/Poultry/Fish
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.9B
IPO Year
2004
1987

Fundamental Metrics

Financial Performance
Metric
CYTK
PPC
Price
$64.86
$41.66
Analyst Decision
Strong Buy
Hold
Analyst Count
16
3
Target Price
$82.38
$46.33
AVG Volume (30 Days)
2.2M
912.7K
Earning Date
02-26-2026
02-11-2026
Dividend Yield
N/A
20.79%
EPS Growth
N/A
24.34
EPS
N/A
5.16
Revenue
$87,211,000.00
$18,351,780,000.00
Revenue This Year
$346.43
$3.95
Revenue Next Year
$57.69
$0.51
P/E Ratio
N/A
$7.83
Revenue Growth
2609.26
1.76
52 Week Low
$29.31
$35.73
52 Week High
$70.98
$57.16

Technical Indicators

Market Signals
Indicator
CYTK
PPC
Relative Strength Index (RSI) 52.99 64.93
Support Level $60.30 $38.29
Resistance Level $65.25 $40.02
Average True Range (ATR) 2.82 0.95
MACD 0.14 0.17
Stochastic Oscillator 73.00 95.81

Price Performance

Historical Comparison
CYTK
PPC

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About PPC Pilgrim's Pride Corporation

Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed that JBS' offer undervalued Pilgrim's Pride.

Share on Social Networks: